Stellar Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-6,631
Closed -$658K 83
2019
Q3
$658K Hold
6,631
0.42% 50
2019
Q2
$626K Hold
6,631
0.41% 53
2019
Q1
$626K Buy
6,631
+100
+2% +$8.75K 0.41% 53
2018
Q4
$419K Sell
6,531
-100
-2% -$7.38K 0.33% 64
2018
Q3
$593K Hold
6,631
0.38% 55
2018
Q2
$527K Hold
6,631
0.35% 56
2018
Q1
$592K Sell
6,631
-9
-0.1% -$864 0.38% 54
2017
Q4
$693K Hold
6,640
0.46% 49
2017
Q3
$968K Sell
6,640
-32
-0.5% -$4.36K 0.68% 47
2017
Q2
$866K Hold
6,672
0.63% 48
2017
Q1
$830K Hold
6,672
0.63% 48
2016
Q4
$772K Buy
+6,672
New +$743K 0.64% 48
2016
Q2
$658K Hold
6,672
0.72% 44
2016
Q1
$668K Hold
6,672
0.74% 45
2015
Q4
$799K Sell
6,672
-200
-3% -$23.1K 0.96% 40
2015
Q3
$743K Buy
6,872
+232
+3% +$28.8K 0.96% 40
2015
Q2
$768K Sell
6,640
-250
-4% -$28.6K 0.84% 44
2015
Q1
$794K Hold
6,890
0.77% 46
2014
Q4
$770K Sell
6,890
-340
-5% -$35.9K 0.83% 43
2014
Q3
$685K Sell
7,230
-60
-0.8% -$5.42K 0.75% 44
2014
Q2
$626K Hold
7,290
0.69% 46
2014
Q1
$509K Sell
7,290
-250
-3% -$19.8K 0.57% 50
2013
Q4
$637K Buy
+7,540
New +$597K 0.68% 48

Other funds holding CELG

Stellar Capital Management's CELG Position: Q4 2019 in Review

Stellar Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 6,631 shares — an estimated $658K sold.

Stellar Capital Management first reported a position in CELG in Q4 2013 and held it in 23 quarters. The position peaked at $968K in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Stellar Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Stellar Capital Management sold 6,631 Celgene Corp shares in Q4 2019, an estimated $658K.
  • Stellar Capital Management first reported a position in Celgene Corp in Q4 2013 and held it in 23 quarters.
  • Stellar Capital Management's Celgene Corp position peaked at $968K in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Stellar Capital Management's 13F filing for Q4 2019, filed 26 Feb 2020.